Tygacil 50 mg
Tygacil 50 mg is a medicine authorised by Swissmedic under authorisation number 57431. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 November 2007 and the authorisation is valid without a time limit. ATC code J01AA12 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 57431 |
|---|---|
| Name | Tygacil 50 mg |
| Full name | Tygacil 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J01AA12 |
| First authorisation | 30 November 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Tygacil 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 30 May 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 10 | Durchstechflasche(n) | J01AA12 | 08.01.5. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tygacil 50 mg authorised in Switzerland?
Yes. Tygacil 50 mg is authorised by Swissmedic under authorisation number 57431, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tygacil 50 mg have?
Tygacil 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tygacil 50 mg?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.